Thousands of men with prostate cancer will be denied life-extending drug

Thousands of men with prostate cancer will be denied life-extending drug after health experts ruled it was not cost effective Life-extending drug for advanced prostate cancer patients was not approved  Abiraterone gives patients extra 15 months on average and cuts the risk of them dying within three years by a third Institute which approves NHS drugs ruled … Read more

Thousands with advanced prostate cancer denied life-extending wonder drug because cost is too high

Thousands of men with advanced prostate cancer will be denied life-extending wonder drug because NHS watchdog says £30,000-a-year cost per treatment is too high The drug abiraterone cuts the risk of men dying within three years by a third  Calls for the drug to be routinely offered to men have been rejected by NICE  The … Read more